The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The In Vitro Diagnostic Packaging Market Grow Between 2026 And 2030?
The in vitro diagnostic packaging market size has experienced robust growth in recent years. It is projected to expand from $10.04 billion in 2025 to $10.82 billion in 2026, showing a compound annual growth rate (CAGR) of 7.8%. This historical growth was driven by factors such as the rising adoption of in vitro diagnostic testing, the expansion of clinical laboratory infrastructure, increasing demand for accurate disease diagnosis, growth of global healthcare expenditure, and the availability of advanced packaging materials.
The in vitro diagnostic packaging market size is anticipated to undergo significant growth in the coming years, projected to reach $14.51 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.6%. This expected expansion during the forecast period can be attributed to the increasing development of point-of-care diagnostics, a heightened focus on sustainable medical packaging, the broadening scope of molecular diagnostics testing, rising investments in healthcare infrastructure, and an escalating emphasis on supply chain safety and integrity. Key trends within the forecast period include a surging demand for sterile and contamination-resistant packaging, the growing adoption of tamper-evident ivd packaging solutions, an increased use of high-barrier plastic and glass materials, the expansion of customized packaging for diagnostic kits, and an enhanced concentration on regulatory-compliant packaging designs.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24250&type=smp
Which Important Drivers Are Guiding The In Vitro Diagnostic Packaging Market Growth?
The increasing incidence and prevalence of chronic diseases and infections are anticipated to drive the expansion of the in vitro diagnostic (IVD) packaging market in the coming years. Chronic diseases and infections refer to persistent health conditions or illnesses caused by pathogens that endure over time, often leading to long-term medical complications. The rising occurrence and widespread nature of these conditions can be attributed to increased exposure to pathogens, with lifestyle choices such as poor diet and insufficient physical activity being significant contributing factors. In vitro diagnostic (IVD) packaging addresses chronic diseases and infections by ensuring the safe, reliable, and efficient delivery of diagnostic tests, which enables early detection and timely treatment, ultimately improving patient outcomes and healthcare efficiency. For instance, in March 2025, information published by the UK Health Security Agency, a UK-based executive agency, revealed that in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023. This marked a nearly sevenfold increase from the 53 cases documented in 2022, with the West Midlands and London accounting for 44% and 33% of these cases, respectively. Therefore, the surge in the incidence and prevalence of chronic diseases and infections is a key driver for the in vitro diagnostic packaging market.
How Is Segmentation Applied In The In Vitro Diagnostic Packaging Market Segment Analysis?
The in vitro diagnostic packaging market covered in this report is segmented –
1) By Packaging Type: Primary Packaging, Secondary Packaging, Tertiary Packaging
2) By Product: Bottles And Vials, Tubes, Petri Dishes, Closures, Other Products
3) By Material Type: Plastic, Glass, Metal, Composite Materials
4) By Application Area: Biochemistry, Microbiology, Immunology, Molecular Diagnostics
5) By End User: Hospitals, Laboratories, Academic Institutes, Other End Users
Subsegments:
1) By Primary Packaging: Cartridges, Microplates, Sample Collection Containers, Reagent Reservoirs, Diagnostic Cassettes, Dropper Bottles
2) By Secondary Packaging: Folding Cartons, Paperboard Sleeves, Trays, Multi-Compartment Boxes, Label Sets, Instruction Leaflets
3) By Tertiary Packaging: Corrugated Shipping Boxes, Pallets, Insulated Shippers, Foam Inserts Or Cushioning, Tamper-Evident Seals, Bulk Transport Containers
What Trends Are Influencing The Evolution Of The In Vitro Diagnostic Packaging Market?
Key companies operating in the in vitro diagnostic packaging industry are prioritizing the development of innovative products, such as sustainable IVD packaging solutions, to enhance environmental responsibility and minimize the ecological impact of diagnostic product containers. A sustainable IVD (in vitro diagnostic) packaging solution involves utilizing eco-friendly materials and practices in diagnostic product packaging, aiming to reduce environmental harm while ensuring product safety and integrity. For instance, in March 2025, Oxford Gene Technology IP Limited, a UK-based provider of diagnostic genomic solutions, introduced an updated environmentally sustainable packaging solution for its CytoCell product range. This innovative packaging incorporates biodegradable and recyclable materials, aligning with the industry’s increasing move towards environmentally conscious practices. The redesigned packaging not only supports a more sustainable method for product disposal but also simplifies laboratory processes through streamlined and easily accessible digital documentation. This initiative highlights the company’s dedication to reducing waste while improving operational efficiency in the clinical and diagnostic sectors.
Who Are The Companies Participating In The In Vitro Diagnostic Packaging Market Environment?
Major companies operating in the in vitro diagnostic packaging market are Thermo Fisher Scientific Inc., Siemens Healthineers, Amcor plc, Corning Incorporated, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ProAmpac, DiaSorin S.p.A., Stevanato Group S.p.A., Sarstedt AG & Co. KG, Greiner AG, Phillips Medisize, Scantibodies Laboratory Inc., Sanner GmbH, DWK Life Sciences, MML Diagnostics Packaging Inc., TCS Biosciences Ltd., Thousand Peak Glass Bottle Co. Ltd., Gerresheimer AG, SCHOTT AG, Berry Global Inc., West Pharmaceutical Services Inc., SGD Pharma, Nipro Corporation
Get The Full In Vitro Diagnostic Packaging Market Report:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostic-packaging-global-market-report
Which Region Leads The In Vitro Diagnostic Packaging Market In Overall Market Size?
North America was the largest region in the in vitro diagnostic packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized In Vitro Diagnostic Packaging Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=24250&type=smp
Browse Through More Reports Similar to the Global In Vitro Diagnostic Packaging Market 2026, By The Business Research Company
In Vitro Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report
Pharmaceutical Packaging Testing Equipment Market Report 2026
Healthcare Packaging Market Report 2026
https://www.thebusinessresearchcompany.com/report/healthcare-packaging-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model